Morningstar
•
Nov 02, 2026
IDEXX Laboratories, Inc.: Idexx Labs Earnings: Stellar Quarterly Performance Leads to Bump in Management Outlook
Summary
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Illumina, Inc.
Oct 30, 2026
•
ILMN
Analyst Report: DexCom, Inc.
Oct 30, 2026
•
DXCM
Analyst Report: ResMed Inc.
Oct 30, 2026
•
RMD
Analyst Report: Illumina, Inc.
Oct 29, 2026
•
ILMN
Analyst Report: Align Technology, Inc.
Oct 29, 2026
•
ALGN
Analyst Profile
Debbie S. Wang
Senior Equity Analyst
Debbie Wang is a senior equity analyst for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. She covers the medical-device industry. Previously, she was an associate director of equity analysis for Morningstar, leading the healthcare team.Before joining Morningstar in 2002, Wang was a vice president and senior brand strategist for Leo Burnett. During her tenure at Leo Burnett, she led brand strategy on a variety of accounts, including Allstate, Amoco, McDonald/s, Heinz, Smucker’s, Pepto-Bismol, and Celebrex.Wang holds a bachelor’s degree in anthropology from Colgate University and a master’s degree in business administration from the University of Chicago Booth School of Business.
